Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luqi Decoction (Luqi Tang) is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for the treatment of chronic heart failure (CHF), specifically Stage C. The formula's name is derived from its primary components: *Lu Rong* (Velvet Antler) and *Huang Qi* (Astragalus membranaceus). It is designed to address the TCM syndrome of Qi and Yang deficiency, which is common in advanced heart failure. Luqi Decoction is intended to improve cardiac function, reduce symptoms, and enhance the quality of life for patients when used as an adjunct to standard Western medical treatments. It has been evaluated in prospective multicenter clinical trials (e.g., ChiCTR2000036954) to establish evidence-based guidelines for TCM in heart failure management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Luqi Decoction.